Skip to main navigation Skip to search Skip to main content

An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial

Project: Research

Project Details

StatusFinished
Effective start/end date12/6/22 → 02/1/25

Funding

  • Global Blood Therapeutics